Skip to main content

20 - References

References

586 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 5 Pre-school children Treatment of anxiety disorders in pre-­school children must routinely focus on ­psychotherapy. In rare cases when a very young child has extreme ongoing symptoms and impairment, clinicians should reconsider diagnosis and case formulation, and reassess the adequacy of the psychotherapy trial. There are no RCTs of pharmacological interventions for anxiety in pre-­school children, but case reports suggest a potential benefit of fluoxetine and buspirone.17 Any prescription in pre-­school children is off-­label.18 References

  1. Kessler RC, et al. Lifetime prevalence and age-­of-­onset distributions of DSM-­IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:­593–­602.
  2. Merikangas KR, et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey ­Replication –­ Adolescent Supplement (NCS-­A). J Am Acad Child Adolesc Psychiatry 2010; 49:­980–­989.
  3. Simonoff E, et al. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-­derived sample. J Am Acad Child Adolesc Psychiatry 2008; 47:­921–­929.
  4. Danese A, et al. Adverse childhood experiences, allostasis, allostatic load, and age-­related disease. Physiol Behav 2012; 106:­29–­39.
  5. Pine DS, et al. The risk for early-­adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry 1998; 55:­56–­64.
  6. National Institute for Health and Clinical Excellence. Social anxiety disorder: recognition, assessment and treatment. Clinical Guidance [CG159]. 2013 (last updated 2017, last checked December 2023); https://www.nice.org.uk/guidance/cg159.
  7. Connolly SD, et al. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2007; 46:­267–­283.
  8. Arnardóttir A, et al. Comparative effectiveness of cognitive behavioral treatment, serotonin, and serotonin noradrenaline reuptake inhibitors for anxiety in children and adolescents: a network meta-­analysis. Nord J Psychiatry 2023; 77:­118–­126.
  9. Dobson ET, et al. Efficacy and tolerability of pharmacotherapy for pediatric anxiety disorders: a network meta-­analysis. J Clin Psychiatry 2019; 80:17r12064.
  10. Walkup JT, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med 2008; 359:­2753–­2766.
  11. Wang Z, et al. Comparative effectiveness and safety of cognitive behavioral therapy and pharmacotherapy for childhood anxiety disorders: a systematic review and meta-­analysis. JAMA Pediatrics 2017; 171:­1049–­1056.
  12. Strawn JR, et al. The impact of antidepressant dose and class on treatment response in pediatric anxiety disorders: a meta-­analysis. J Am Acad Child Adolesc Psychiatry 2018; 57:­235–­244.e232.
  13. Stefánsdóttir ÍH, et al. Efficacy and safety of serotonin reuptake inhibitors (SSRI) and serotonin noradrenaline reuptake inhibitors (SNRI) for children and adolescents with anxiety disorders: a systematic review and meta-­analysis. Nord J Psychiatry 2023; 77:­137–­146.
  14. Solmi M, et al. Safety of 80 antidepressants, antipsychotics, anti-­attention-­deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-­review of 78 adverse effects. World Psychiatry 2020; 19:­214–­232.
  15. Strawn JR, et al. Buspirone in children and adolescents with anxiety: a review and Bayesian analysis of abandoned randomized controlled trials. J Child Adolesc Psychopharmacol 2018; 28:­2–­9.
  16. Strawn JR, et al. Extended release guanfacine in pediatric anxiety disorders: a pilot, randomized, placebo-­controlled trial. J Child Adolesc Psychopharmacol 2017; 27:­29–­37.
  17. Gleason MM, et al. Psychopharmacological treatment for very young children: contexts and guidelines. J Am Acad Child Adolesc Psychiatry 2007; 46:­1532–­1572.
  18. Mohatt J, et al. Treatment of separation, generalized, and social anxiety disorders in youths. Am J Psychiatry 2014; 171:­741–­748.

No comments to display

Back to top